Airway Medix S.A. 将获得 200 万欧元，用于项目开发与商业化
Airway Medix 与 CoOpera、Kröner Medizintechnik 及一家瑞士集团签署两份投资协议，金额最高 200 万欧元。资金将用于公司三款专利产品的开发与商业化。
全文为英文（原文）
Warsaw, November 16, 2023: Airway Medix has signed two Investment Agreements with CoOpera Finanzierungen Deutschland, Kröner Medizintechnik and a Swiss advisory and investment group. Partners will invest up to EUR 2 million, enabling the continuation of commercialization of innovative medical products on the EU, US, Asian and South American markets.
Three finished products, with international patents, focus on supporting patients' mechanical ventilation. Kröner Medizintechnik, CEO Peter Kröner, will be operationally and strategically involved in the company's development, covering production processes.
The partners, using their experience in the medical industry, granted the Company a EUR 900,000 loan, enabling it to complete negotiations and start business talks. The goal is to quickly commercialize products and develop synergies with partners' experience in the distribution of medical equipment.
About Airway Medix S.A.: Airway Medix S.A. focuses on the research, development and commercialization of innovative single-use devices for mechanically ventilated patients in Intensive Care Units (ICUs), as well as life-threatening patients and anesthesiology departments. The products offered by Airway Medix address the most pressing clinical needs and fill a gap in current medical devices. Airway Medix S.A. has been listed on the Warsaw Stock Exchange since 2014.
新闻稿以 Airway Medix S.A. 发布时的原文为准。产品相关表述以使用说明书为依据。
